Elli Papaemmanuil

VP Translational Medicine Oncology Genentech

Co-founder

2025Global Vice President Translational Medicine Oncology· Genentech

Founder · since 2020

Company

Genentech

Role

Global Vice President Translational Medicine Oncology

current

Stage

—

no public source

Raised

—

no public source

Based

San Francisco Bay Area

current

Founder / co-founder — the company's markEmployee / research role

Profile coverage5 of 7 · missing posts, contact

Isabl

Cancer tests based on whole genome and transcriptome data.

Experience

Career

Genentech
Global Vice President Translational Medicine Oncology · San Francisco Bay Area · 2025 – Present
2025
Isabl
Co-founder
Co-Founder and CEO · NYC · 2020 – 2026
2020
University of Cambridge
Junior Team Leader · Cambridge, United Kingdom · 2016 – 2025
2016
MSKCC
Associate Professor Computational Oncology Service · Greater New York City Area · 2015 – 2025
2015
Pharmaceutical Sector | Genomics Companies | Precision Medicine | Technology Architecture
Scientific Advisory Board Member · Internationally · 2016 – 2025
2016
Wellcome Trust Sanger Institute
Senior Post doctoral research fellow · 2010 – 2014
2010
Deloitte
IT consultant · 2009 – 2010
2009
The Institute of Cancer Research
Postdoctoral Researcher · London, United Kingdom · 2008 – 2009
2008
The Institute of Cancer Research
PHD Student · Sutton, United Kingdom · 2004 – 2008
2004
AstraZeneca
Industry placement R&D Pharmacogenetics · Alderley Park Manchester · 2002 – 2003
2002